SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: VLAD who wrote (7712)5/4/1998 6:52:00 PM
From: Bradpalm1  Read Replies (4) of 23519
 
Last Friday, a Vivus 'Primary Care Consultant' detailed our office for the very first time. Her presentation was very professional and she answered questions about Muse, Viagra and other ED alternatives very honestly and directly.

She left each physician with a marketing packet containing a reprint of the Jan. '97 NEJM Muse article, a reprint about Erectile Dysfunction from Patient Care (PCP throw away journal), a Muse Patient Information pamphlet and a laminated Muse Prescribing Information Card.

Overall I was impressed by what I saw and heard but felt that this should have been done 6-8 months ago when Viagra was still awaiting submission of its NDA. My perceptions about Vivus and Muse and Viagra on this thread are pretty well known. However, I must say that Vivus appears to be on the right track as far as reaching PCPs (primary care physicians) about Muse.

Bradpalm1
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext